Skip to main content

Table 2 Associations between biogenesis genes and cancer risk for those SNPs that had a raw p-value of <0.05

From: Impact of polymorphisms in microRNA biogenesis genes on colon cancer risk and microRNA expression levels: a population-based, case-control study

 

Controls

Cases

 

N

%

N

%

OR

(95 % CI)

P-valuea,b

P Holmb

VEP Prediction

AGO2 (rs6985156)

 GG

912

77.7

858

77.0

1.00

 

0.030

0.395

 

 GA

250

21.3

230

20.6

0.98

(0.80, 1.20)

   

 AA

11

0.9

27

2.4

2.59

(1.27, 5.26)

   

 GG/GA vs. AA

11

0.9

27

2.4

2.6

(1.28, 5.28)

  

Modifier

AGO2 (rs7843258)

 CC

810

69.1

779

69.9

1.00

 

0.031

0.395

 

 CT

342

29.2

298

26.7

0.90

(0.75, 1.08)

   

 TT

21

1.8

38

3.4

1.87

(1.09, 3.23)

   

 CC/CT vs.TT

21

1.8

38

3.4

1.93

(1.12, 3.32)

  

Modifier

AGO2 (rs2176397)

 CC

567

48.3

568

50.9

1.00

 

0.019

0.273

 

 CT

517

44.1

435

39.0

0.85

(0.71, 1.01)

   

 TT

89

7.6

112

10.0

1.26

(0.93, 1.71)

   

 CC/CT vs. TT

89

7.6

112

10

1.36

(1.02, 1.83)

  

Modifier

AGO2 (rs4961278)

 AA

605

51.6

578

51.8

1.00

 

0.032

0.395

 

 AG

501

42.7

444

39.8

0.92

(0.78, 1.09)

   

 GG

67

5.7

93

8.3

1.45

(1.04, 2.03)

   

 AA/AG vs. GG

67

5.7

93

8.3

1.51

(1.09, 2.09)

  

Modifier

BMP2 (rs3178250)

 TT

747

63.7

663

59.5

1.00

 

0.014

0.040

 

 TC

371

31.6

415

37.2

1.24

(1.04, 1.48)

   

 CC

55

4.7

37

3.3

0.75

(0.49, 1.16)

   

 TT vs.TC/CC

426

36.3

452

40.5

1.18

(0.99, 1.40)

  

Modifier

DGCR8 (rs11089328)

 AA

400

34.1

432

38.7

1.00

 

0.009

0.066

 

 AG

586

50.0

491

44.0

0.76

(0.63, 0.91)

   

 GG

187

15.9

192

17.2

0.94

(0.74, 1.20)

   

 AA vs. AG/GG

773

65.9

683

61.3

0.80

(0.68, 0.96)

  

Modifier

DROSHA (rs2287584)

 TT

743

63.3

742

66.5

1.00

 

0.032

0.384

 

 TC

394

33.6

325

29.1

0.82

(0.69, 0.99)

   

 CC

36

3.1

48

4.3

1.33

(0.85, 2.08)

   

 TT/TC vs. CC

36

3.1

48

4.3

1.42

(0.91, 2.20)

  

Low

DROSHA (rs17410035)

 GG

552

47.1

468

42.0

1.00

 

0.014

0.181

 

 GT

473

40.3

518

46.5

1.29

(1.08, 1.53)

   

 TT

148

12.6

129

11.6

1.01

(0.77, 1.32)

   

 GG vs. GT/TT

621

52.9

647

58.0

1.22

(1.03, 1.44)

  

Modifierc

GEMIN4 (rs2740348)

 CC

782

66.7

798

71.6

1.00

 

0.048

0.241

 

 CG

352

30.0

286

25.7

0.80

(0.67, 0.96)

   

 GG

39

3.3

31

2.8

0.78

(0.48, 1.27)

   

 CC vs. CG/GG

391

33.3

317

28.4

0.80

(0.67, 0.96)

  

Moderate

MAPKAPK2 (rs4548444)

 AA

713

60.8

686

61.5

1.00

 

0.021

0.041

 

 AG

417

35.5

363

32.6

0.91

(0.76, 1.08)

   

 GG

43

3.7

66

5.9

1.61

(1.08, 2.40)

   

 AA/AG vs. GG

43

3.7

66

5.9

1.67

(1.12, 2.48)

  

Modifier

PRKRA (rs10207436)

 AA

616

52.5

655

58.7

1.00

 

0.013

0.026

 

 AG

480

40.9

400

35.9

0.78

(0.66, 0.93)

   

 GG

77

6.6

60

5.4

0.75

(0.52, 1.07)

   

 AA vs. AG/GG

557

47.5

460

41.3

0.78

(0.66, 0.92)

  

Modifier

  1. a Adjusted for age, sex and center
  2. b These p-values are for the co-dominant model only
  3. c This SNP is predicted to have a ‘modifier’ effect for C5orf22 by VEP